CSPC Pharmaceutical Group Limited: Neoplasms trials

The registry lists 27 Neoplasms studies with CSPC Pharmaceutical Group Limited as lead sponsor. 12 are open to participants now and 0 have results posted.

Phase 1 23Phase 2 5Phase 4 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SYS6088 in Patients With Advanced/Metastatic Solid TumorsNot yet recruitingNCT07857135Phase 1/2
• Evaluation of SYS6005 in Patients With Advanced Malignant TumorRecruitingNCT06958679Phase 1
• A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid TumorsRecruitingNCT06632574Phase 1
• A Study to Evaluate the Efficacy of ALMB-0168 in Solid Tumor Patients With Bone Metastatic Whose Prior Standard Treatment Have FailedNot yet recruitingNCT06416358Phase 2
• A Study of NBL-028 in Patients With Advanced Solid TumorsRecruitingNCT06223256Phase 1
• A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.RecruitingNCT05877924Phase 1
• Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant TumorsNot yet recruitingNCT05728541Phase 1
• A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid TumorsNot yet recruitingNCT05609019Phase 1
• A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid TumorsNot yet recruitingNCT05508659Phase 1/2
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid TumorsNot yet recruitingNCT05478785Phase 1/2
• To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT05407909Phase 1
• Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid TumorsNot yet recruitingNCT05153096Phase 1
• A Study of DP303c in Patients With HER2-positive Advanced Solid TumorsStatus unknownNCT05810103Phase 1
• A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid TumorsStatus unknownNCT05508620Phase 1
• A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid TumorsStatus unknownNCT05344742Phase 1
• A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid TumorsStatus unknownNCT05125523Phase 1
• A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid TumorsStatus unknownNCT05114915Phase 1
• A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant TumorSuspendedNCT05089461Phase 2
• A Study of SKLB1028 in Patients With Advanced Solid TumorStatus unknownNCT05072522Phase 1
• A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid TumorsCompletedNCT04921878Phase 1
• A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid TumorStatus unknownNCT04719065Phase 1
• Efficacy and Safety of JMT101 in Patients With Advanced Solid TumorStatus unknownNCT04689100Phase 1
• A Study of CSPCHA131 in Patients With Advanced Solid TumorStatus unknownNCT04325711Phase 1
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid TumorsStatus unknownNCT04309968Phase 1
• Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant TumorsCompletedNCT04060290
• A Phase I Trial of Simmitinib in Advanced Solid TumorsStatus unknownNCT04058587Phase 1
• PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving ChemotherapyCompletedNCT02805166Phase 4